Персона: Епишкина, Анна Алексеевна
Загружается...
Email Address
Birth Date
Научные группы
Организационные подразделения
Организационная единица
Инженерно-физический институт биомедицины
Цель ИФИБ и стратегия развития – это подготовка высококвалифицированных кадров на базе передовых исследований и разработок новых перспективных методов и материалов в области инженерно-физической биомедицины. Занятие лидерских позиций в биомедицинских технологиях XXI века и внедрение их в образовательный процесс, что отвечает решению практикоориентированной задачи мирового уровня – диагностике и терапии на клеточном уровне социально-значимых заболеваний человека.
Статус
Фамилия
Епишкина
Имя
Анна Алексеевна
Имя
4 results
Результаты поиска
Теперь показываю 1 - 4 из 4
- ПубликацияТолько метаданныеSynthesis and In Silico Prediction of the Molecular-Targeting Anti-EGFR Action of a Novel Dihydroacridinone(2024) Epishkina, A. A.; Bogoslovskaya, E. V.; Pakina, V. A.; Blinova, E. V.; Епишкина, Анна Алексеевна; Блинова, Екатерина Валериевна
- ПубликацияОткрытый доступAn effective way for targeting EGFR-mediated carcinogenesis: an in vitro study(2024) Pakina, V. A.; Epishkina, A. A.; Grebenkin, E. V.; Blinova, E. V.; Епишкина, Анна Алексеевна; Гребенкин, Евгений Валерьевич; Блинова, Екатерина ВалериевнаIntroduction: EGFR-activating overexpression or somatic mutations are common in different human cancers. In this regard, the search for promising ways to control the carcinogenic transformation of tumor cells and the progression of malignant tumors expressing EGFR seems to be one of the most promising and developing areas of modern molecular pathology and pharmacology. Material and Methods: An antitumor activity of a novel compound, a pyridine carboxylic acid derivative LHT-17-19, was studied. The molecule was developed and synthesized at the Department of Chemistry, Drug Design and Technology of All-Russian Research Center for Biological Active Compounds Safety (Russia). The study was carried out in cell cultures of stomach cancer (Hs746T, AGS and MKN1) and patient-derived organoid (PDO) model of breast cancer (BC) expressing wild-type EGFR. Results: It was shown that LHT-17-19 induced concentration-dependent cytotoxicity of EGFR-expressing gastric cancer cells of all the aforementioned cultures. Pathomorphological, immunohistochemical and molecular validation of BC organoids derived from ductal breast carcinoma cells of a 68-year-old patient was done. PDOs were established as ER-negative, PR-negative, Her2/neu-negative, EGFR-positive with 35% of the Ki-67 expression index. In addition, the tumor cells translocation was resulted in a loss of ER expression and PDOs molecular pattern conversion towards a more aggressive triple negative type. PDOs incubation with 0.5-60.0 ‚?M LHT-17-19 was accompanied not only by inhibition of their growth and proliferation, but also by significant cytoreduction. Conclusion: Thus, in two-dimensional and three-dimensional tumor cell cultures, the possibility of controlling the oncogenic expression of EGFR with the acridone compound 9-ammonium-3,3-dimethyl-3,4-dihydroacridine-1(2H)-OH L-2-hydroxybutanedivacate (LHT-17-19) was shown.
- ПубликацияТолько метаданныеAdenosquamous Carcinoma in the Epithelial Inclusion Cyst of The Vagina - Rare Clinical Case Report(2024) Grebenkin, E. V.; Kondrashova, L. M.; Untesco, M.; Epishkina, A. A.; Епишкина, Анна Алексеевна
- ПубликацияОткрытый доступMetanephric adenoma of the kidney: clinical case and literature review Метанефральная аденома почки: клиническии случаи и обзор литературы(2023) Grebenkin, E. V.; Pshikhachev, A. M.; Osmolovskiy, B. E.; Epishkina, A. A.; Гребенкин, Евгений Валерьевич; Епишкина, Анна АлексеевнаMetanephric adenoma is a rare benign kidney tumor with a favorable prognosis. These neoplasms are often interpreted as malignant at the preoperative stage, since they do not have specific characteristics showing during instrumental imaging methods, which leads to excessive surgical treatment in the context of nephrectomy volume. Therefore, histological verification is the gold standard for diagnosis. The morphological features of metanephric adenoma are in many ways similar to such kidney tumors as papillary renal cell carcinoma and nephroblastoma (Wilms’ tumor), so sometimes additional research methods are required, including immunohistochemical and molecular genetic ones. In this article, we report a rare clinical case of metanephric adenoma in a forty-seven-year-old woman. The results of clinical and instrumental exams, as well as morphological features of the tumor are presented. A review of the literature on the clinical, morphological, and molecular aspects of this tumor is also presented.